DaVita Inc. Schedules Special Investor Conference Call
DaVita Inc. (NYSE: DVA) announced a special investor conference call scheduled for June 23, 2022, at 8:45 a.m. EDT. The call follows a U.S. Supreme Court ruling concerning the Medicare Secondary Payor Act. Investors can join the call via a designated phone number or listen to a webcast. DaVita is focused on enhancing kidney care, having served 200,800 patients at 2,809 outpatient dialysis centers in the U.S. as of March 31, 2022. The company aims to improve patient outcomes and accessibility in kidney health.
- DaVita operates 2,809 outpatient dialysis centers in the U.S., emphasizing its extensive service network.
- The company is recognized for clinical quality and innovation in kidney care for over 20 years.
- None.
DENVER, June 22, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today it will hold a special conference call with investors on Thursday, June 23, 2022, at 8:45 a.m. Eastern Time. This call follows this week's U.S. Supreme Court ruling regarding the Medicare Secondary Payor Act.
You can join this call as follows:
Thursday, June 23, 2022
Starting at 8:45 a.m. EDT
Dial in number: 877-918-6630
International dial in: 517-308-9042
Webcast: investors.davita.com
When calling in, please provide the operator the password "DaVita" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
About DaVita Inc. DaVita (NYSE: DVA) is a comprehensive kidney care provider focused on transforming care to improve the quality of life for patients globally. The company is a leading provider of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita is working to help increase equitable access to care for patients at every stage and setting along their kidney health journey—from slowing progression of kidney disease to streamlining the transplant process, from acute hospital care to dialysis at home. As of March 31, 2022, DaVita served 200,800 patients at 2,809 outpatient dialysis centers in the U.S. The company operated an additional 346 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality and worked collaboratively to help propel the kidney care community to adopt an equitable, high-quality standard of care for patients around the globe. To learn more, visit DaVita.com/About.
Contact Information
Investors:
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-special-investor-conference-call-301573212.html
SOURCE DaVita Inc.
FAQ
What is the purpose of the DaVita conference call on June 23, 2022?
How can investors join the DaVita conference call?
What is the current number of patients served by DaVita?
What is DaVita's business focus?
Where can I find more information about DaVita's services?
